[
  {
    "section": "section:1",
    "title": "Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer"
  },
  {
    "section": "section:2",
    "title": "PATIENTS AND METHODS"
  },
  {
    "section": "section:3",
    "title": "Patient Population"
  },
  {
    "section": "section:3",
    "title": "Treatment"
  },
  {
    "section": "section:3",
    "title": "Objectives and Statistical Plan"
  },
  {
    "section": "section:2",
    "title": "RESULTS"
  },
  {
    "section": "section:2",
    "title": "DISCUSSION"
  },
  {
    "section": "section:2",
    "title": "REFERENCES"
  }
]